RRM in One Paragraph
Restorative Reproductive Medicine is an approach that aims to diagnose and treat the underlying medical causes of infertility rather than bypassing them with assisted reproductive technology (ART). Where conventional reproductive endocrinology might proceed to IUI or IVF after initial workup, RRM physicians spend more time investigating hormonal imbalances, ovulatory dysfunction, endometriosis, thyroid issues, and other root causes — and attempt to correct them medically so natural conception can occur.
What RRM Treats
- Ovulatory dysfunction: Using targeted hormonal support (progesterone supplementation, letrozole, clomiphene) timed to the patient’s actual cycle rather than a standard protocol.
- Endometriosis: Surgical excision (not ablation) followed by hormonal optimization.
- PCOS: Insulin sensitizers (metformin, inositol), weight management, and ovulation induction.
- Luteal phase deficiency: Progesterone support timed to confirm post-ovulatory rise.
- Male factor: Hormonal optimization, varicocele repair, lifestyle and supplement protocols.
The Controversy
RRM has roots in Catholic medical ethics — the NaProTechnology program (Natural Procreative Technology) was developed at the Pope Paul VI Institute by Dr. Thomas Hilgers. Many RRM practitioners are faith-motivated, and some oppose IVF on religious grounds. This creates concern that RRM is being promoted as a faith-based alternative to evidence-based ART, and that mandating its coverage (as Arkansas did) is legislating religious beliefs into healthcare.
The counterargument: diagnosing and treating root causes of infertility is good medicine regardless of the practitioner’s motivation. Many of the interventions RRM uses (letrozole, progesterone support, excision surgery) are mainstream and evidence-based. The question is whether RRM as a framework adds anything beyond standard RE practice.
What RRM gets right: Emphasis on diagnosis before treatment. Many patients feel rushed to IVF when underlying causes haven’t been fully explored. Root-cause treatment, when possible, is cheaper, less invasive, and more sustainable than ART.
What RRM gets wrong (or at least incomplete): Some cases genuinely require IVF — severe male factor, bilateral tubal obstruction, diminished ovarian reserve. RRM practitioners who refuse to refer to ART when appropriate are doing patients a disservice. Additionally, the evidence base for NaProTechnology specifically is thin — most studies are retrospective, small, and conducted by affiliated institutions.
The policy concern: Mandating RRM coverage while restricting IVF coverage (as some proposals suggest) limits patient choice. Both should be covered, letting patients and their doctors choose the appropriate path.